Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

A Phase I Dose-Escalation Study Of The Selective PKC-beta Inhibitor MS-553 In Patients With CLL/SLL

Protocol: OSU-17239

Full Title

A Phase I Dose-Escalation Study Of The Selective PKC-beta Inhibitor MS-553 In Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Leukemia Chronic Lymphocytic Leukemia Lymphoma